drugset / Trial / NCT01371487

GSK1120212 Food-effect Study

NCT01371487

Phase 1 Completed 40 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the this study is to evaluate the effect of a high-fat, high calorie meal on the single dose PK of GSK1120212 in subjects with solid tumors.

Timeline

Start
2011-05-02
Primary completion
2011-09-30
Completion
2011-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Trametinib Small molecule 2 mg Oral

Indications